In a study led by research team from France, receptor–ligand pair of CD161–lectin-like transcript 1 (LLT) has a positive impact on survival of patients suffered from non-small cell lung carcinoma (P = 0.016, HR = 0.88) (Braud et al. 2018). The gene discussed is CLEC2D; the disease is non-small cell lung carcinoma.